Redeye retains its positive view of Sdiptech following a Q1 report that was stronger than our expectations. The company continues to perform strongly with organic growth figures well above peers and sustained margins. We expect continued solid organic growth, healthy margins and strong cash flows ahead. We continue to view the stock as attractive and maintain our base case fair value per share.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Sdiptech - Silencing its critics

© Modular Finance, source Nordic Press Releases